This is how they roll

This is how they roll

Late yesterday afternoon Dexcom (NASDAQ:DXCM) stated in a press release; “DexCom, Inc. (Nasdaq: DXCM) today reported preliminary unaudited revenues of approximately $105 million for the quarter ended September 30, 2015, an increase of $36 million, or 52%, year over year. Dexcom’s third quarter 2015 revenues are preliminary and subject to adjustment as the Company evaluates the impact of any revenue deferral related to the upgrade programs announced in connection with the Company’s G5 Mobile launch.”

After a rough 30 days shares of the company are up huge in early trading this morning.

Frankly this news doesn’t surprise Diabetic Investor as we have maintained all along that Dexcom is the posterchild for how a diabetes device company should be run. Dexcom is one of the few device companies that actually gets it that understands the value of putting the patient first. The biggest problem with this company has never been performance, the biggest problem has been and will continue to be meeting ever growing expectations. Expectations that have grown even larger now that they have partnered with Google.

Now we don’t want to delude anyone as there will be dips in the road that it will not be a straight line to success. Even the best companies stumble from time to time. Yet with its seasoned management team which has deep roots in diabetes Diabetic Investor is confident that company win over the long term. As my boys like to say – This is how they roll and roll they will.